RSS-Feed abonnieren
PDF herunterladen
DOI: 10.1055/a-2513-9400
Creation of an Interactive Dashboard to Facilitate Early Detection of Cardiac Amyloidosis in African American Veterans
Funding This project is the result of work supported with resources from VA facilities in Tampa, Greater Los Angeles, and Tucson. This project was funded in part by an independent quality improvement grant from Pfizer Inc. to Arizona State University to address healthcare barriers for cardiac amyloidosis that contribute to geographic and racial disparities. The sponsor had no role in project design or execution. The content does not represent the views of the U.S. Department of Veteran Affairs nor the United States government.
Abstract
Background Cardiac amyloidosis (CA) is an underdiagnosed cause of heart failure (HF) that disproportionately impacts men of African descent. Without a standardized method of screening and scattered patient health information, clinicians must integrate data that spans multiple disease systems and is stored across the electronic health record.
Objectives The aim of this project was to create a dashboard to facilitate identification of high-risk African American (AA) veterans who would benefit from CA screening tests. This paper described the development of the dashboard and identified barriers and opportunities in dashboard development.
Methods Three Veterans Affairs (VA) health systems participated in this project. Microsoft Structured Query Language (SQL) Report Builder was utilized to create an interactive dashboard that refreshes daily through stored procedures using SQL Server Integration Services and the SQL Server Job Agent. Inclusion criteria included AA patients less than 90 years old with a history of HF. The 2023 American College of Cardiology/American Heart Association consensus statement on diagnosis and treatment of transthyretin CA was the source of evidence in creating the inclusion criteria and parameters of interest.
Results The final dashboard contained 1,732 HF patients who met inclusion criteria, of which 949 (55%) were identified as high risk. We faced several challenges in this project, including time required for dashboard development, limited team experience in specifying dashboard requirements, identifying informatics counterparts at all sites, and standardizing data across three VA hospitals.
Conclusion In this clinical improvement project, we created a dashboard that identifies AA veterans with HF at risk for CA and that can help to mitigate the impact of CA on this population.
Protection of Human and Animal Subjects
Each site's institutional review board determined the project to be quality improvement and not research.
Publikationsverlauf
Eingereicht: 19. Juli 2024
Angenommen: 08. Januar 2025
Artikel online veröffentlicht:
14. Mai 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
-
References
- 1 Roger VL. Epidemiology of heart failure: a contemporary perspective. Circ Res 2021; 128 (10) 1421-1434
- 2 Rapezzi C, Lorenzini M, Longhi S. et al. Cardiac amyloidosis: the great pretender. Heart Fail Rev 2015; 20 (02) 117-124
- 3 Martinez-Naharro A, Hawkins PN, Fontana M. Cardiac amyloidosis. Clin Med (Lond) 2018; 18 (Suppl. 02) s30-s35
- 4 Aimo A, Merlo M, Porcari A. et al. Redefining the epidemiology of cardiac amyloidosis. A systematic review and meta-analysis of screening studies. Eur J Heart Fail 2022; 24 (12) 2342-2351
- 5 Chandrashekar P, Alhuneafat L, Mannello M. et al. Prevalence and outcomes of p.Val142Ile TTR amyloidosis cardiomyopathy: a systematic review. Circ Genom Precis Med 2021; 14 (05) e003356
- 6 Gilstrap LG, Dominici F, Wang Y. et al. Epidemiology of cardiac amyloidosis-associated heart failure hospitalizations among fee-for-service Medicare beneficiaries in the United States. Circ Heart Fail 2019; 12 (06) e005407
- 7 Washington DLJL, Kasom DR, Canning M. et al. National Veteran Health Equity Report - Black or African American Veteran Chartbook. Focus on Veterans Health Administration Patient Experience and Health Care Quality. VHA Off Health Equity 2023
- 8 Maurer MS, Schwartz JH, Gundapaneni B. et al; ATTR-ACT Study Investigators. Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy. N Engl J Med 2018; 379 (11) 1007-1016
- 9 Heidenreich PA, Bozkurt B, Aguilar D. et al; ACC/AHA Joint Committee Members. 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines. Circulation 2022; 145 (18) e895-e1032
- 10 Kiourtis A, Mavrogiorgou A, Mavrogiorgos K. et al. Electronic health records at people's hands across Europe: the InteropEHRate protocols. Stud Health Technol Inform 2022; 299: 145-150
- 11 Kittleson MM, Ruberg FL, Ambardekar AV. et al; Writing Committee. 2023 ACC expert consensus decision pathway on comprehensive multidisciplinary care for the patient with cardiac amyloidosis: a report of the American College of Cardiology solution set oversight committee. J Am Coll Cardiol 2023; 81 (11) 1076-1126
- 12 Ghazisaeidi M, Safdari R, Torabi M, Mirzaee M, Farzi J, Goodini A. Development of performance dashboards in healthcare sector: key practical issues. Acta Inform Med 2015; 23 (05) 317-321
- 13 Makic MBF, Stevens KR, Gritz RM. et al. Dashboard design to identify and balance competing risk of multiple hospital-acquired conditions. Appl Clin Inform 2022; 13 (03) 621-631
- 14 Miller R, Coyne E, Crowgey EL. et al. Implementation of a learning healthcare system for sickle cell disease. JAMIA Open 2020; 3 (03) 349-359
- 15 Szczesniak RD, Brokamp C, Su W, Mcphail GL, Pestian J, Clancy JP. Improving detection of rapid cystic fibrosis disease progression-early translation of a predictive algorithm into a point-of-care tool. IEEE J Transl Eng Health Med 2018; 7: 2800108
- 16 Rescic N, Alberts J, Altenburg TM. et al. SmartCHANGE: AI-based long-term health risk evaluation for driving behaviour change strategies in children and youth. Int Conference Applied Mathematics Comp Sci 2023
- 17 Kiourtis A, Mavrogiorgou A, Zafeiropoulos N, Mavrogiorgos K, Karabetian A, Kyriazis D. UI/UX sustainable design: best practices for applications co2 emissions reduction. 2024 9th International Conference on Smart and Sustainable Technologies (SpliTech). 2024
- 18 Rahmawati N, Suroto S, Syah T, Kurniawan T, Ramadani R. Hotel administration application design using Delphi and UI/UX designer. Internet Things Artificial Intelligence J 2024; 4 (03) 395-405
- 19 Kittleson MM, Maurer MS, Ambardekar AV. et al; American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology. Cardiac amyloidosis: evolving diagnosis and management: a scientific statement from the American Heart Association. Circulation 2020; 142 (01) e7-e22
- 20 Davies DR, Redfield MM, Scott CG. et al. A simple score to identify increased risk of transthyretin amyloid cardiomyopathy in heart failure with preserved ejection fraction. JAMA Cardiol 2022; 7 (10) 1036-1044
- 21 Writing Committee Members. ACC/AHA Joint Committee Members. 2022 AHA/ACC/HFSA guideline for the management of heart failure. J Card Fail 2022; 28 (05) e1-e167
- 22 Chang ICY, Bois JP, Bois MC, Maleszewski JJ, Johnson GB, Grogan M. Hydroxychloroquine-mediated cardiotoxicity with a false-positive 99mtechnetium-labeled pyrophosphate scan for transthyretin-related cardiac amyloidosis. Circ Cardiovasc Imaging 2018; 11 (01) e007059
- 23 Russell LE, Cohen AJ, Chrzas S. et al. Implementing a social needs screening and referral program among veterans: assessing circumstances & offering resources for needs (ACORN). J Gen Intern Med 2023; 38 (13) 2906-2913
- 24 Shenvi E, Boxwala A, Sittig D. et al. Visualization of patient-generated health data: a scoping review of dashboard designs. Appl Clin Inform 2023; 14 (05) 913-922
- 25 Moya A, Oeste CL, Beles M. et al. Detection of transthyretin amyloid cardiomyopathy by automated data extraction from electronic health records. ESC Heart Fail 2023; 10 (06) 3483-3492
- 26 Hysong SJ, Yang C, Wong J, Knox MK, O'Mahen P, Petersen LA. Beyond information design: designing health care dashboards for evidence-driven decision-making. Appl Clin Inform 2023; 14 (03) 465-469
- 27 Willis C, Watanabe AH, Hughes J. et al. Applying diagnosis support systems in electronic health records to identify wild-type transthyretin amyloid cardiomyopathy risk. Future Cardiol 2022; 18 (05) 367-376
- 28 Grogan M, Lopez-Jimenez F, Cohen-Shelly M. et al. Artificial intelligence-enhanced electrocardiogram for the early detection of cardiac amyloidosis. Mayo Clin Proc 2021; 96 (11) 2768-2778
- 29 Duffy G, Cheng PP, Yuan N. et al. High-throughput precision phenotyping of left ventricular hypertrophy with cardiovascular deep learning. JAMA Cardiol 2022; 7 (04) 386-395